The Cryogenic OGS IPO introduces a precision engineering company specializing in the design, fabrication, and supply of metering and filtration equipment for the oil, gas, chemical, and allied fluid industries. Operating from a fully integrated 8,300 sq. meter facility in Vadodara, Gujarat, Cryogenic OGS Limited serves both public sector undertakings and private clients, offering products such as basket strainers, prover tanks, and loading skids. Its future strategy focuses on turnkey projects, innovation-led development, and global expansion through collaborations, positioning the Cryogenic OGS IPO as a notable opportunity in the industrial manufacturing sector.
₹30
₹47
₹89.30
Expert Opinions
The Cryogenic OGS IPO is drawing positive market sentiment, supported by strong financial growth and healthy investor interest. The company’s strengths include a 32% year-on-year revenue increase in FY 2025, a 15% rise in net profit, and a debt-free balance sheet, reflecting operational efficiency and prudent management. Cryogenic OGS’s expertise in manufacturing metering and filtration equipment for oil, gas, and chemical industries, along with a lean workforce and robust client base, further enhances its appeal.
However, risks include its relatively small scale, sectoral cyclicality, and reliance on a limited number of large clients, which could impact future growth. For FY 2025, the Cryogenic OGS IPO valuation metrics—Return on Equity (ROE) at 23.62%, Return on Capital Employed (ROCE) at 28.93%, and Net Asset Value (NAV) of ₹27.61—indicate solid fundamentals. From a long-term perspective, the company’s focus on innovation and global expansion offers promise, but investors should monitor sector-specific risks.
Investor Considerations
Investors considering the Cryogenic OGS IPO should note the company’s consistent financial performance, with FY 2025 revenue rising 32% year-on-year to ₹33.79 crore and PAT up 15% to ₹6.12 crore, alongside a debt-free balance sheet and growing net worth. The sector outlook is favorable, as demand for high-quality metering and filtration equipment in oil, gas, and chemical industries remains robust. The Cryogenic OGS IPO valuation appears reasonable, with a Price to Book Value of 1.70, PAT margin of 18.61%, and EBITDA margin of 24.20%, reflecting solid profitability and operational efficiency.
Growth prospects are supported by innovation, turnkey project expansion, and increasing international bids, though current revenue is highly concentrated in Gujarat and Maharashtra, and export share is still low. Key risks include project dependency and limited geographic diversification. While short-term gains are possible, the Cryogenic OGS IPO is best suited for investors with a medium- to long-term horizon seeking steady sectoral growth.
| Date | GMP | Trend |
|---|---|---|
| 09 Jul 2025 10.51 | ₹30 | --- |
| 08 Jul 2025 12.04 | ₹30 | Up |
| 07 Jul 2025 10.49 | ₹25 | --- |
| 06 Jul 2025 17.08 | ₹25 | --- |
| 05 Jul 2025 10.28 | ₹25 | --- |
| 04 Jul 2025 17.48 | ₹25 | Up |
| 02 Jul 2025 16.04 | ₹20 | --- |
FAQs
The Grey Market Premium showed low accuracy in predicting Cryogenic OGS IPO’s listing performance. With a final GMP of ₹30, it projected a premium of 63.83% over the issue price of ₹47. However, the stock listed much higher at ₹89.30, delivering a massive gain of 90%. This resulted in a prediction error of 26.17%, where the GMP correctly signaled a strong positive listing but substantially underestimated the actual gains, reflecting limited reliability in this case.
Cryogenic OGS IPO Current GMP is ₹30.
Cryogenic OGS IPO Expected Returns is 63.83%.
Cryogenic OGS IPO estimated listing price is ₹77.